← FDA DRUG APPROVALS

FDA ANDA · ANDA080399

DEXAMETHASONE

Sponsor: PRASCO

APPLICATION
ANDA080399
TYPE
ANDA
ORIGINAL APPROVAL
1971-10-20
LATEST ACTION
2024-06-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued, Prescription

Products

DEXAMETHASONEDiscontinued
DEXAMETHASONE 0.75MG · TABLET · ORAL
DEXAMETHASONEPrescription
DEXAMETHASONE 4MG · TABLET · ORAL

Approval history

2024-06-05Labeling · Supplement 80 · standardAP
2022-08-15Manufacturing (CMC) · Supplement 79 · unknownAP
1984-01-20Manufacturing (CMC) · Supplement 75AP
1983-07-27Manufacturing (CMC) · Supplement 74AP
1982-09-27Manufacturing (CMC) · Supplement 72AP
1982-09-27Manufacturing (CMC) · Supplement 70AP
1982-08-03Manufacturing (CMC) · Supplement 73AP
1971-10-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →